Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

A. Pecora; M. S.Perez Aguirreburualde; D. Rodriguez; C. Seki; M. S. Levy; D. Bochoeyer; M. J. Dus Santos; A. Wigdorovitz

doi:10.1016/j.jviromet.2009.07.031

Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

A. Pecora, M. S.Perez Aguirreburualde, D. Rodriguez, C. Seki, M. S. Levy, D. Bochoeyer, M. J. Dus Santos, A. Wigdorovitz

Veterinary Population Medicine

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Bovine Viral Diarrhea Virus (BVDV) is the causative agent of a worldwide disease. The virus infects bovines of all ages, causing reproductive problems and contaminating biological products of high commercial value. The large-scale production of BVDV vaccines presents the challenge of processing antigenic proteins that are highly susceptible to the processing environment. Potency testing requires the immunization of cattle in order to determine the neutralizing antibodies titers induced by the vaccine. An alternative to the in vivo test is an in vitro measurement of key viral antigens. This paper describes the development and validation of a sandwich-type indirect ELISA that is able to detect and quantify BVDV E2 glycoprotein in live and inactivated BVDV. Validation parameters such as repeatability, intermediate precision, and reproducibility indicated that the developed ELISA constitutes an advanced tool for evaluating the BVDV antigen throughout manufacturing and vaccine release testing.

Original language	English (US)
Pages (from-to)	170-178
Number of pages	9
Journal	Journal of Virological Methods
Volume	162
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jviromet.2009.07.031
State	Published - Jan 2009

Keywords

BVDV
ELISA
Validation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.jviromet.2009.07.031

Find It

Find It at U of M Libraries

Cite this

Pecora, A., Aguirreburualde, M. S. P., Rodriguez, D., Seki, C., Levy, M. S., Bochoeyer, D., Dus Santos, M. J., & Wigdorovitz, A. (2009). Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production. Journal of Virological Methods, 162(1-2), 170-178. https://doi.org/10.1016/j.jviromet.2009.07.031

Pecora, A, Aguirreburualde, MSP, Rodriguez, D, Seki, C, Levy, MS, Bochoeyer, D, Dus Santos, MJ & Wigdorovitz, A 2009, 'Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production', Journal of Virological Methods, vol. 162, no. 1-2, pp. 170-178. https://doi.org/10.1016/j.jviromet.2009.07.031

@article{061b559c051b461687762462ba01616b,

title = "Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production",

abstract = "Bovine Viral Diarrhea Virus (BVDV) is the causative agent of a worldwide disease. The virus infects bovines of all ages, causing reproductive problems and contaminating biological products of high commercial value. The large-scale production of BVDV vaccines presents the challenge of processing antigenic proteins that are highly susceptible to the processing environment. Potency testing requires the immunization of cattle in order to determine the neutralizing antibodies titers induced by the vaccine. An alternative to the in vivo test is an in vitro measurement of key viral antigens. This paper describes the development and validation of a sandwich-type indirect ELISA that is able to detect and quantify BVDV E2 glycoprotein in live and inactivated BVDV. Validation parameters such as repeatability, intermediate precision, and reproducibility indicated that the developed ELISA constitutes an advanced tool for evaluating the BVDV antigen throughout manufacturing and vaccine release testing.",

keywords = "BVDV, ELISA, Validation",

author = "A. Pecora and Aguirreburualde, {M. S.Perez} and D. Rodriguez and C. Seki and Levy, {M. S.} and D. Bochoeyer and {Dus Santos}, {M. J.} and A. Wigdorovitz",

year = "2009",

month = jan,

doi = "10.1016/j.jviromet.2009.07.031",

language = "English (US)",

volume = "162",

pages = "170--178",

journal = "Journal of Virological Methods",

issn = "0166-0934",

publisher = "Elsevier B.V.",

number = "1-2",

}

TY - JOUR

T1 - Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

AU - Pecora, A.

AU - Aguirreburualde, M. S.Perez

AU - Rodriguez, D.

AU - Seki, C.

AU - Levy, M. S.

AU - Bochoeyer, D.

AU - Dus Santos, M. J.

AU - Wigdorovitz, A.

PY - 2009/1

Y1 - 2009/1

N2 - Bovine Viral Diarrhea Virus (BVDV) is the causative agent of a worldwide disease. The virus infects bovines of all ages, causing reproductive problems and contaminating biological products of high commercial value. The large-scale production of BVDV vaccines presents the challenge of processing antigenic proteins that are highly susceptible to the processing environment. Potency testing requires the immunization of cattle in order to determine the neutralizing antibodies titers induced by the vaccine. An alternative to the in vivo test is an in vitro measurement of key viral antigens. This paper describes the development and validation of a sandwich-type indirect ELISA that is able to detect and quantify BVDV E2 glycoprotein in live and inactivated BVDV. Validation parameters such as repeatability, intermediate precision, and reproducibility indicated that the developed ELISA constitutes an advanced tool for evaluating the BVDV antigen throughout manufacturing and vaccine release testing.

AB - Bovine Viral Diarrhea Virus (BVDV) is the causative agent of a worldwide disease. The virus infects bovines of all ages, causing reproductive problems and contaminating biological products of high commercial value. The large-scale production of BVDV vaccines presents the challenge of processing antigenic proteins that are highly susceptible to the processing environment. Potency testing requires the immunization of cattle in order to determine the neutralizing antibodies titers induced by the vaccine. An alternative to the in vivo test is an in vitro measurement of key viral antigens. This paper describes the development and validation of a sandwich-type indirect ELISA that is able to detect and quantify BVDV E2 glycoprotein in live and inactivated BVDV. Validation parameters such as repeatability, intermediate precision, and reproducibility indicated that the developed ELISA constitutes an advanced tool for evaluating the BVDV antigen throughout manufacturing and vaccine release testing.

KW - BVDV

KW - ELISA

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=70349746737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349746737&partnerID=8YFLogxK

U2 - 10.1016/j.jviromet.2009.07.031

DO - 10.1016/j.jviromet.2009.07.031

M3 - Article

C2 - 19665482

AN - SCOPUS:70349746737

SN - 0166-0934

VL - 162

SP - 170

EP - 178

JO - Journal of Virological Methods

JF - Journal of Virological Methods

IS - 1-2

ER -

Development and validation of an ELISA for quantitation of Bovine Viral Diarrhea Virus antigen in the critical stages of vaccine production

Abstract

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this